Dr. Cataldo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Inverness Center Pkwy
Ste 210
Hoover, AL 35242Phone+1 205-509-0700Fax+1 205-509-0724
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 1981 - 1985
- Harvard Medical SchoolClass of 1981
Certifications & Licensure
- CA State Medical License 1983 - 2025
- AL State Medical License 2004 - 2024
- IN State Medical License 2013 - 2023
- TN State Medical License 2015 - 2018
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Publications & Presentations
PubMed
- 2 citationsAssessing Human Immunodeficiency Virus (HIV) Prevention Through Knowledge and Condom Use Among Female Sex Workers at the Border of Haiti and Dominican RepublicHenna Budhwani, Kristine R. Hearld, Julia Hasbun, Sarah Franklin, Bijal G. Vashi
AIDS Patient Care and Stds. 2020-11-02 - 5 citationsExamining the Use of Magnesium Sulfate to Treat Pregnant Women with Preeclampsia and Eclampsia: Results of a Program Assessment of Emergency Obstetric Care (EmOC) Trai...Henna Budhwani, Poonam V Shivkumar, C. N. Purandare, Nicholas A. Cataldo, Sadhana K. Desai
Journal of Obstetrics and Gynaecology of India. 2017-02-10 - 48 citationsVitamin D Status Relates to Reproductive Outcome in Women With Polycystic Ovary Syndrome: Secondary Analysis of a Multicenter Randomized Controlled TrialLubna Pal, Heping Zhang, Joanne Williams, Nanette Santoro, Michael P. Diamond
The Journal of Clinical Endocrinology and Metabolism. 2016-05-17
Press Mentions
- INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business UpdateAugust 16th, 2021
- INVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint Venture INVOcell Clinic in the United StatesMarch 15th, 2021
Grant Support
- Rosiglitazone And Clomiphene For Ovulation InductionNational Center For Research Resources2005
- Troglitazone And Clomiphene For Ovulation InductionNational Center For Research Resources2004
- Rosiglitazone In Polycystic Ovary SyndromeNational Center For Research Resources2004
- Rosiglitazone In Polycystic Ovary SyndromeEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
- Rosiglitazone And Clomiphene For Ovulation InductionEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
- FAS And Bc1-2 And Granulosa Cell ApoptosisEunice Kennedy Shriver National Institute Of Child Health &Human Development1997–2000
- Troglitazone And Clomiphene For Ovulation InductionEunice Kennedy Shriver National Institute Of Child Health &Human Development1998
- FAS And Bc1-2 And Granulosa Cell ApoptosisEunice Kennedy Shriver National Institute Of Child Health &Human Development1996
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: